158 related articles for article (PubMed ID: 31759828)
21. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.
Boshoff C; Weiss RA
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):517-34. PubMed ID: 11313009
[TBL] [Abstract][Full Text] [Related]
22. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus.
Boshoff C; Chang Y
Annu Rev Med; 2001; 52():453-70. PubMed ID: 11160789
[TBL] [Abstract][Full Text] [Related]
24. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
Verma SC; Robertson ES
FEMS Microbiol Lett; 2003 May; 222(2):155-63. PubMed ID: 12770701
[TBL] [Abstract][Full Text] [Related]
25. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis.
Gasperini P; Sakakibara S; Tosato G
J Leukoc Biol; 2008 Oct; 84(4):994-1000. PubMed ID: 18319288
[TBL] [Abstract][Full Text] [Related]
26. The biology of Kaposi's sarcoma.
Herndier B; Ganem D
Cancer Treat Res; 2001; 104():89-126. PubMed ID: 11191137
[No Abstract] [Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated polyclonal body cavity effusions that mimic primary effusion lymphomas.
Ascoli V; Calabrò ML; Giannakakis K; Barbierato M; Chieco-Bianchi L; Gastaldi R; Narciso P; Gaidano G; Capello D
Int J Cancer; 2006 Oct; 119(7):1746-8; author reply 1749-50. PubMed ID: 16671085
[No Abstract] [Full Text] [Related]
28. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
29. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
31. Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS.
Cavallin LE; Goldschmidt-Clermont P; Mesri EA
PLoS Pathog; 2014 Jul; 10(7):e1004154. PubMed ID: 25010730
[No Abstract] [Full Text] [Related]
32. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of AIDS--related Kaposi's sarcoma. Evidence of a viral etiology.
Miles SA
Hematol Oncol Clin North Am; 1996 Oct; 10(5):1011-21. PubMed ID: 8880193
[TBL] [Abstract][Full Text] [Related]
34. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.
Reed JA; Nador RG; Spaulding D; Tani Y; Cesarman E; Knowles DM
Blood; 1998 May; 91(10):3825-32. PubMed ID: 9573020
[TBL] [Abstract][Full Text] [Related]
37. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
38. Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.
Marshall V; Parks T; Bagni R; Wang CD; Samols MA; Hu J; Wyvil KM; Aleman K; Little RF; Yarchoan R; Renne R; Whitby D
J Infect Dis; 2007 Mar; 195(5):645-59. PubMed ID: 17262705
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
Aoki Y; Tosato G
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis.
Sharp TV; Boshoff C
IUBMB Life; 2000 Feb; 49(2):97-104. PubMed ID: 10776590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
